Designing Longevity
Skip to main content

Teduglutide (Gattex)

Teduglutide, sold as Gattex in the U.S., is a prescription GLP-2 analog approved for patients ages 1 and older with short bowel syndrome who depend on parenteral support, meaning fluids or nutrition delivered into a vein.

Sources reviewed November 13, 2026 · How we work

How teduglutide works

Teduglutide acts like the hormone glucagon-like peptide-2, or GLP-2. With short bowel syndrome, it can help the remaining intestine absorb more fluid and nutrients. Gattex is supplied as a powder for injection in a 5 mg single-dose vial.

Sources for this section

What the study measured

In a 24-week trial in adults, 27 of 43 treated with teduglutide and 13 of 43 given placebo reached the label’s trial outcome of at least a 20% reduction in weekly IV support volume at both weeks 20 and 24. Reducing support volume is a distinct outcome from coming off IV support entirely.

Sources for this section

What specialist monitoring covers

Specialists coordinate the evaluation for intestinal polyps, monitor for obstruction, fluid overload and gallbladder or pancreatic problems, and review medicines that may be absorbed differently during treatment. The care team also manages any changes to IV nutrition or fluids.

Sources for this section
Explore Gut Health & Digestion